These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26163684)

  • 41. Estimating the distribution of the window period for recent HIV infections: a comparison of statistical methods.
    Sweeting MJ; De Angelis D; Parry J; Suligoi B
    Stat Med; 2010 Dec; 29(30):3194-202. PubMed ID: 21170913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing evidence for behaviour change affecting the course of HIV epidemics: a new mathematical modelling approach and application to data from Zimbabwe.
    Hallett TB; Gregson S; Mugurungi O; Gonese E; Garnett GP
    Epidemics; 2009 Jun; 1(2):108-17. PubMed ID: 21352758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Epidemiological analysis on recent infected HIV-1 patients among newly reported HIV cases in Beijing, from 2009 to 2011].
    Chen Q; Li Y; Su X; Hao M; Lu H; He X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jan; 35(1):53-6. PubMed ID: 24685038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measuring trends in prevalence and incidence of HIV infection in countries with generalised epidemics.
    Ghys PD; Kufa E; George MV
    Sex Transm Infect; 2006 Apr; 82 Suppl 1(Suppl 1):i52-6. PubMed ID: 16581761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence, incidence, mortality and co-morbidities amongst human immunodeficiency virus (HIV) patients in Stockholm County, Sweden - the Greater Stockholm HIV Cohort Study.
    Jallow A; Ljunggren G; Wändell P; Carlsson AC
    AIDS Care; 2015; 27(2):142-9. PubMed ID: 25277328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Definition and estimation of an actual reproduction number describing past infectious disease transmission: application to HIV epidemics among homosexual men in Denmark, Norway and Sweden.
    Amundsen EJ; Stigum H; Røttingen JA; Aalen OO
    Epidemiol Infect; 2004 Dec; 132(6):1139-49. PubMed ID: 15635973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative interpretation of Sedia LAg Assay test results after HIV diagnosis.
    Sempa JB; Grebe E; Welte A
    PLoS One; 2022; 17(7):e0271763. PubMed ID: 35901053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of BED HIV-1 incidence assay in seroconverter cohorts: effect of individuals with long-term infection and importance of stable incidence.
    McNicholl JM; McDougal JS; Wasinrapee P; Branson BM; Martin M; Tappero JW; Mock PA; Green TA; Hu DJ; Parekh B;
    PLoS One; 2011 Mar; 6(3):e14748. PubMed ID: 21408214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling of the HIV epidemic and continuum of care in French Guiana.
    Nacher M; Adriouch L; Huber F; Vantilcke V; Djossou F; Elenga N; Adenis A; Couppié P
    PLoS One; 2018; 13(5):e0197990. PubMed ID: 29795698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. UNAIDS Reference Group on estimates, modelling and projections--statement on the use of the BED assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring.
    Wkly Epidemiol Rec; 2006 Jan; 81(4):40. PubMed ID: 16671237
    [No Abstract]   [Full Text] [Related]  

  • 51. Estimating epidemiological parameters of a stochastic differential model of HIV dynamics using hierarchical Bayesian statistics.
    Dale R; Guo B
    PLoS One; 2018; 13(7):e0200126. PubMed ID: 30044818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimation of HIV incidence using multiple biomarkers.
    Brookmeyer R; Konikoff J; Laeyendecker O; Eshleman SH
    Am J Epidemiol; 2013 Feb; 177(3):264-72. PubMed ID: 23302151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How should we best estimate the mean recency duration for the BED method?
    Hargrove J; Eastwood H; Mahiane G; van Schalkwyk C
    PLoS One; 2012; 7(11):e49661. PubMed ID: 23166743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On the statistical accuracy of biomarker assays for HIV incidence.
    Brookmeyer R
    J Acquir Immune Defic Syndr; 2010 Aug; 54(4):406-14. PubMed ID: 20436353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bayesian back-calculation using a multi-state model with application to HIV.
    Sweeting MJ; De Angelis D; Aalen OO
    Stat Med; 2005 Dec; 24(24):3991-4007. PubMed ID: 16320278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statistical considerations for cross-sectional HIV incidence estimation based on recency test.
    Gao F; Bannick M
    Stat Med; 2022 Apr; 41(8):1446-1461. PubMed ID: 34984710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An enhanced cross-sectional HIV incidence estimator that incorporates prior HIV test results.
    Bannick M; Donnell D; Hayes R; Laeyendecker O; Gao F
    Stat Med; 2024 Jul; 43(17):3125-3139. PubMed ID: 38803064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimating HIV incidence from case-report data: method and an application in Colombia.
    Vesga JF; Cori A; van Sighem A; Hallett TB
    AIDS; 2014 Nov; 28 Suppl 4(4):S489-96. PubMed ID: 25406752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sample size methods for estimating HIV incidence from cross-sectional surveys.
    Konikoff J; Brookmeyer R
    Biometrics; 2015 Dec; 71(4):1121-9. PubMed ID: 26302040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new general biomarker-based incidence estimator.
    Kassanjee R; McWalter TA; Bärnighausen T; Welte A
    Epidemiology; 2012 Sep; 23(5):721-8. PubMed ID: 22627902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.